Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • rating
  • Page 5

Tag: rating

Morgan Stanley Maintained a Buy Rating on Loar Holdings (LOAR), Kept the PT Unchanged
Posted in Business

Morgan Stanley Maintained a Buy Rating on Loar Holdings (LOAR), Kept the PT Unchanged

Estimated read time 2 min read
Posted on June 30, 2025
by Joelgalvan

Loar Holdings Inc. (NYSE:LOAR) is one of the 13 Best Aerospace and Defense Stocks to Invest in Now. On June 13,…

Learn More Leave a Comment on Morgan Stanley Maintained a Buy Rating on Loar Holdings (LOAR), Kept the PT Unchanged
Craig-Hallum Reiterates a Buy Rating on Anterix (ATEX)
Posted in Business

Craig-Hallum Reiterates a Buy Rating on Anterix (ATEX)

Estimated read time 2 min read
Posted on June 26, 2025
by Joelgalvan

Anterix Inc (NASDAQ:ATEX) is one of the 13 Small Cap Stocks Analysts Are Bullish On. On April 10, Craig-Hallum analyst…

Learn More Leave a Comment on Craig-Hallum Reiterates a Buy Rating on Anterix (ATEX)
Susquehanna Raised the PT on Taiwan Semiconductor Manufacturing (TSM), Keeping a Buy Rating
Posted in Business

Susquehanna Raised the PT on Taiwan Semiconductor Manufacturing (TSM), Keeping a Buy Rating

Estimated read time 2 min read
Posted on June 26, 2025
by Joelgalvan

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the 12 Best Stocks to Buy and Hold for the Long Term.…

Learn More Leave a Comment on Susquehanna Raised the PT on Taiwan Semiconductor Manufacturing (TSM), Keeping a Buy Rating
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Posted in Business

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

Estimated read time 2 min read
Posted on June 25, 2025
by Joelgalvan

Barclays lowered its price target on Bausch & Lomb (NYSE: BLCO) from $19 to $16 on June 6, maintaining an…

Learn More Leave a Comment on Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating
Posted in Business

Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating

Estimated read time 2 min read
Posted on June 24, 2025
by Joelgalvan

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)  is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. Gena Wang of…

Learn More Leave a Comment on Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating
Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating
Posted in Business

Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating

Estimated read time 2 min read
Posted on June 23, 2025
by Joelgalvan

The Home Depot, Inc. (NYSE:HD) is one of the best dividend stocks according to Jim Cramer. TD Cowen reiterated a…

Learn More Leave a Comment on Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating
JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating
Posted in Business

JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating

Estimated read time 2 min read
Posted on June 22, 2025
by Joelgalvan

Occidental Petroleum Corporation (NYSE:OXY) is one of the 10 Best Oil and Gas Stocks to Buy Now. On May 9,…

Learn More Leave a Comment on JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating
Wells Fargo Raises PT for Williams Companies (WMB), Keeps Overweight Rating
Posted in Business

Wells Fargo Raises PT for Williams Companies (WMB), Keeps Overweight Rating

Estimated read time 2 min read
Posted on June 22, 2025
by Joelgalvan

The Williams Companies, Inc. (NYSE:WMB) is one of the 10 Best Oil and Gas Stocks to Buy Now. On May…

Learn More Leave a Comment on Wells Fargo Raises PT for Williams Companies (WMB), Keeps Overweight Rating
Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110
Posted in Business

Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110

Estimated read time 2 min read
Posted on June 20, 2025
by Joelgalvan

Insmed Inc. (NASDAQ:INSM) is one of the 10 best growth stocks to buy according to billionaires. On June 10, Mizuho analyst…

Learn More Leave a Comment on Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110
TD Cowen Lowers Lam Research (LRCX) Price Target, Keeps Buy Rating
Posted in Business

TD Cowen Lowers Lam Research (LRCX) Price Target, Keeps Buy Rating

Estimated read time 2 min read
Posted on June 19, 2025
by Joelgalvan

Lam Research Corporation (NASDAQ:LRCX) is one of the 10 Best American Semiconductor Stocks to Buy Now. On April 24, TD…

Learn More Leave a Comment on TD Cowen Lowers Lam Research (LRCX) Price Target, Keeps Buy Rating

Posts navigation

← Older Articles
Newer Articles →

Recent Posts

  • Giants’ pitching staff dwindles as Landen Roupp hits IL
  • 3 Key Signs You’re Losing Money By Saving Too Much
  • NHL analyst voices concern over Hockey Canada sexual assault trial verdict
  • Viktor Gyokeres: Arsenal’s new signing is a graduate of IF Brommapojkarna, the Swedish club with ‘no fans’ but Europe’s biggest academy | Football News
  • Cathie Wood Just Loaded Up on This High-Flying Crypto Stock. Should You Follow Her Lead?

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.